Astrocytes, long dismissed as brain support staff, actively gate neuronal signals to control cognition and behavior, upending decades of neuroscience dogma.
Story Highlights
- OHSU’s 2025 Science paper proves astrocytes process information in real-time using fruit fly and rodent models.
- These star-shaped cells, 35% of brain cells, respond to dopamine and glutamate to selectively activate or silence synapses.
- Findings challenge neuron-only views, opening doors to therapies for Alzheimer’s, Parkinson’s, anxiety, and mood disorders.
- Conserved mechanisms across species suggest human relevance for revolutionizing brain treatments.
- Expert consensus positions astrocytes as computational powerhouses parsing the brain’s signal chaos.
Astrocytes Emerge from Scientific Shadows
Marc Freeman’s team at OHSU Vollum Institute imaged live fruit fly brains on May 15, 2025, capturing astrocytes responding to neurotransmitters. Dopamine and glutamate triggered calcium waves that gated synaptic inputs. Astrocytes turned specific neuron circuits on or off, managing information flow. This real-time control orchestrated network activity for behavior. Replication in rodents confirmed conservation, hinting at universal brain mechanics.
Historical Dismissal Gives Way to Active Role
Neuroscience fixated on neurons pre-2016, ignoring glia that form half the brain. Astrocytes supplied nutrients and cleared waste under that model. Freeman’s 2016 work first showed them signaling between neurons. Calcium imaging in the 2020s revealed synapse coordination for memory. OHSU’s 2025 study detailed gating: astrocytes parsed neurotransmitter cacophony, selectively boosting relevant signals while suppressing noise.
Sarah Guttenplan highlighted astrocytes’ power: they control neuronal activity dynamically. Each astrocyte contacts up to 100,000 synapses, enabling precise computation. This complexity explains why past models overlooked them. NIH’s Miriam Leenders praised fly insights as broadly applicable.
Key Players Drive Paradigm Shift
OHSU leads with Freeman directing Vollum Institute efforts. NINDS funds via Leenders, prioritizing translational neuroscience. Guttenplan decoded gating mechanisms. MIT’s Jean-Jacques Slotine modeled astrocytes enabling vast memory via synapse networks. Tufts researchers linked them to epilepsy and Alzheimer’s in mice. These collaborations validate findings, fueling pharma interest in glial drugs.
Recent Breakthroughs Reshape Understanding
May 2025 brought OHSU’s Science publication and MIT’s memory hypothesis. Freeman stated the work changes astrocyte views and therapy development. Guttenplan emphasized powerful neuronal control. Findings persist in mammals, suggesting human trials. Tufts opens epilepsy paths. Ongoing research targets glial dysfunction in neurodegeneration, promising evidence-based interventions over hasty neuron fixes.
Short-term, models now include astrocytes for accurate simulations. Long-term, drugs hit glial targets for Parkinson’s and mood disorders. Patients gain hope; biotech eyes markets beyond neurons. NIH shifts funding to whole-brain views, aligning with fiscal prudence in research dollars. Whole-brain imaging exposes neglected regions, demanding unbiased approaches.
Sources:
OHSU study reveals impact of oft-overlooked cell in brain function
Overlooked cells might explain human brain’s huge storage capacity
Discovery of new function performed by nearly half of brain cells
